Navigation Links
InspireMD Completes First Phase of Manufacturing Upgrade and Partners with HealthLink for Global Logistics and Distribution Services
Date:8/26/2013

BOSTON, Aug. 26, 2013 /PRNewswire/ -- InspireMD, Inc. (NYSE MKT: NSPR) ("InspireMD" or the "Company"), a leader in embolic protection stents, today announced it has completed the first phase of a manufacturing consolidation that the Company believes will improve its long term gross margins.

Simultaneously, the Company has signed an agreement with HealthLink Europe, a medical device support services and distribution company, to provide logistical and customer support for InspireMD's commercial operations and clinical activities.  HealthLink will provide InspireMD with customer service center capabilities for inquiries from hospitals and distributors.  HealthLink will also handle all inventory controls, warehousing, shipping, and invoicing and receivables management for customers worldwide on behalf of InspireMD.

Alan Milinazzo, President and CEO of InspireMD, commented, "We have successfully completed the first stage of our manufacturing strategy through the consolidation of our Israeli manufacturing facilities.  Over time, we believe that this will reduce our operating costs by streamlining our manufacturing operations."

"As we prepare to announce the 12-month results from the MASTER trial in October, we continue to put in place the appropriate infrastructure to be able to meet the anticipated increase in demand for our lifesaving stent technology.  The agreement with HealthLink Europe is intended to support both current commercial activities as well as ongoing clinical trials, and should provide us instant access to world-class customer logistics to support all of our customers through a single partner," concluded Mr. Milinazzo.

Rick Hughes, President of HealthLink Europe, commented "For nearly 20 years HealthLink has built an impressive track record of providing superior customer service and logistics support to the medical d
'/>"/>

SOURCE InspireMD, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. InspireMDs MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group
2. InspireMD Reports Financial Results For Period Ended March 31, 2013
3. InspireMD Receives Approval From US Food and Drug Administration to Begin US Regulatory Trial
4. InspireMD Closes $25 Million Underwritten Public Offering
5. InspireMD Announces Pricing of Underwritten Public Offering of Common Stock and Listing on NYSE MKT
6. InspireMD Receives CE Mark Approval for Carotid Embolic Protection Stent
7. InspireMD Files Amended Registration Statement for Proposed Public Offering of Common Stock
8. InspireMD Reports Results for Period Ended Dec. 31, 2012
9. InspireMD to Discuss MGuard(TM) and the MASTER Randomized Trial Results at the ICI 2012 Meeting
10. Positive Results of InspireMDs MASTER Trial to be Published on November 6 in Journal of American College of Cardiology
11. InspireMD Reports Results For Period Ending Sept. 30, 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... , July 20, 2015 ... the addition of the "Global Post-traumatic Stress Disorder ... The global PTSD therapeutics market to grow at ... This report covers the present scenario and the ... the period 2015-2019. To calculate the market size, the ...
(Date:7/28/2015)... 2015   DigiPath Labs , the cannabis testing ... with True North Laboratory of Ann Arbor, ... leading global supplier of diagnostic solutions for food-borne pathogens, ... rapid diagnostic test kits to screen for food-borne ... "This joint effort is expected to result in the ...
(Date:7/27/2015)... WESTLAKE VILLAGE, Calif. , July 27, 2015 ... KYTHERA Biopharmaceuticals, Inc. (NASDAQ: KYTH ) today announced ... early termination of the waiting period under the Hart-Scott-Rodino ... to Allergan,s pending acquisition of KYTHERA.  ... 6, 2015, each of Allergan and KYTHERA filed a ...
Breaking Medicine Technology:Global Post-traumatic Stress Disorder Therapeutics Market 2015-2019 - Growing Number of Accidents and Violence Worldwide Drives the Market 2DigiPath Labs Partners with Romer Labs to Validate Food-Borne Pathogen and Mycotoxin Testing Solutions for Cannabis 2DigiPath Labs Partners with Romer Labs to Validate Food-Borne Pathogen and Mycotoxin Testing Solutions for Cannabis 3Allergan and KYTHERA Announce Early Termination of Hart-Scott-Rodino Waiting Period for Allergan's Pending Acquisition of KYTHERA 2Allergan and KYTHERA Announce Early Termination of Hart-Scott-Rodino Waiting Period for Allergan's Pending Acquisition of KYTHERA 3Allergan and KYTHERA Announce Early Termination of Hart-Scott-Rodino Waiting Period for Allergan's Pending Acquisition of KYTHERA 4Allergan and KYTHERA Announce Early Termination of Hart-Scott-Rodino Waiting Period for Allergan's Pending Acquisition of KYTHERA 5Allergan and KYTHERA Announce Early Termination of Hart-Scott-Rodino Waiting Period for Allergan's Pending Acquisition of KYTHERA 6Allergan and KYTHERA Announce Early Termination of Hart-Scott-Rodino Waiting Period for Allergan's Pending Acquisition of KYTHERA 7Allergan and KYTHERA Announce Early Termination of Hart-Scott-Rodino Waiting Period for Allergan's Pending Acquisition of KYTHERA 8Allergan and KYTHERA Announce Early Termination of Hart-Scott-Rodino Waiting Period for Allergan's Pending Acquisition of KYTHERA 9
... 14 Reportlinker.com announces that a new market ... Colorectal Cancer - France Drug Forecasts ... http://www.reportlinker.com/p0312710/Colorectal-Cancer---France-Drug-Forecasts-and-Treatment-Analysis-to-2020.html Colorectal Cancer ... 2020 SummaryGlobalData, the industry analysis ...
... Oct. 14 Reportlinker.com announces that a new ... Colorectal Cancer - Brazil, China, ... Treatment Analysis to 2020 ... China, India and Russia (BRIC) Drug Drug Forecasts ...
Cached Medicine Technology:Reportlinker Adds Colorectal Cancer - France Drug Forecasts and Treatment Analysis to 2020 2Reportlinker Adds Colorectal Cancer - France Drug Forecasts and Treatment Analysis to 2020 3Reportlinker Adds Colorectal Cancer - France Drug Forecasts and Treatment Analysis to 2020 4Reportlinker Adds Colorectal Cancer - France Drug Forecasts and Treatment Analysis to 2020 5Reportlinker Adds Colorectal Cancer - France Drug Forecasts and Treatment Analysis to 2020 6Reportlinker Adds Colorectal Cancer - France Drug Forecasts and Treatment Analysis to 2020 7Reportlinker Adds Colorectal Cancer - France Drug Forecasts and Treatment Analysis to 2020 8Reportlinker Adds Colorectal Cancer - France Drug Forecasts and Treatment Analysis to 2020 9Reportlinker Adds Colorectal Cancer - France Drug Forecasts and Treatment Analysis to 2020 10Reportlinker Adds Colorectal Cancer - France Drug Forecasts and Treatment Analysis to 2020 11Reportlinker Adds Colorectal Cancer - France Drug Forecasts and Treatment Analysis to 2020 12Reportlinker Adds Colorectal Cancer - France Drug Forecasts and Treatment Analysis to 2020 13Reportlinker Adds Colorectal Cancer - France Drug Forecasts and Treatment Analysis to 2020 14Reportlinker Adds Colorectal Cancer - France Drug Forecasts and Treatment Analysis to 2020 15Reportlinker Adds Colorectal Cancer - Brazil, China, India and Russia (BRIC) Drug Drug Forecasts and Treatment Analysis to 2020 2Reportlinker Adds Colorectal Cancer - Brazil, China, India and Russia (BRIC) Drug Drug Forecasts and Treatment Analysis to 2020 3Reportlinker Adds Colorectal Cancer - Brazil, China, India and Russia (BRIC) Drug Drug Forecasts and Treatment Analysis to 2020 4Reportlinker Adds Colorectal Cancer - Brazil, China, India and Russia (BRIC) Drug Drug Forecasts and Treatment Analysis to 2020 5Reportlinker Adds Colorectal Cancer - Brazil, China, India and Russia (BRIC) Drug Drug Forecasts and Treatment Analysis to 2020 6Reportlinker Adds Colorectal Cancer - Brazil, China, India and Russia (BRIC) Drug Drug Forecasts and Treatment Analysis to 2020 7Reportlinker Adds Colorectal Cancer - Brazil, China, India and Russia (BRIC) Drug Drug Forecasts and Treatment Analysis to 2020 8Reportlinker Adds Colorectal Cancer - Brazil, China, India and Russia (BRIC) Drug Drug Forecasts and Treatment Analysis to 2020 9Reportlinker Adds Colorectal Cancer - Brazil, China, India and Russia (BRIC) Drug Drug Forecasts and Treatment Analysis to 2020 10Reportlinker Adds Colorectal Cancer - Brazil, China, India and Russia (BRIC) Drug Drug Forecasts and Treatment Analysis to 2020 11Reportlinker Adds Colorectal Cancer - Brazil, China, India and Russia (BRIC) Drug Drug Forecasts and Treatment Analysis to 2020 12Reportlinker Adds Colorectal Cancer - Brazil, China, India and Russia (BRIC) Drug Drug Forecasts and Treatment Analysis to 2020 13Reportlinker Adds Colorectal Cancer - Brazil, China, India and Russia (BRIC) Drug Drug Forecasts and Treatment Analysis to 2020 14Reportlinker Adds Colorectal Cancer - Brazil, China, India and Russia (BRIC) Drug Drug Forecasts and Treatment Analysis to 2020 15
(Date:7/28/2015)... (PRWEB) , ... July 28, 2015 , ... ... developing targeted biologics and biologic-device combination products for the treatment of bone disorders ... issued U.S. Patent No. 9,062,300 entitled "Fusion Proteins of Collagen Binding-Domain and Parathyroid ...
(Date:7/28/2015)... ... ... Women fear developing Alzheimer's disease more than having a heart attack or stroke ... but there is little an individual can do to arrest the progress of Alzheimer's ... reports the July 2015 Harvard Women's Health Watch . , "There are now ...
(Date:7/28/2015)... ... July 28, 2015 , ... ... of Mets' David Wright's Spinal Stenosis Injury" discussed baseball player David Wright’s spinal ... is acquired lumbar stenosis, brought on by degenerative changes in the spine, rather ...
(Date:7/28/2015)... ... July 28, 2015 , ... There has been ... think of highways, bridges and railroads, often overlooked is the over 740,000 miles ... and buildings and into sewage treatment facilities. According to the American Society of ...
(Date:7/28/2015)... ... ... Maryland Brain & Spine has adopted a new name – Maryland Brain, Spine ... techniques, and additional state-of-the art online resources for patients. MBSP is ... and spine conditions. , “Adding the word ‘pain’ may not seem like a ...
Breaking Medicine News(10 mins):Health News:BiologicsMD, Inc. Announces Additional US Patent Issuance Covering Company’s Pipeline of Targeted Therapies 2Health News:Fight Alzheimer's By Taking Part in a Clinical Trial, From the July 2015 Harvard Women's Health Watch 2Health News:Fight Alzheimer's By Taking Part in a Clinical Trial, From the July 2015 Harvard Women's Health Watch 3Health News:Spine Surgeon Weighs in on Uncertain Future Baseball Career Future for David Wright 2Health News:Spine Surgeon Weighs in on Uncertain Future Baseball Career Future for David Wright 3Health News:With an Infrastructure Spending Bill on the Horizon, RestorationEze Discusses the Impact an Aging Sewer System is Having on Homeowners 2Health News:With an Infrastructure Spending Bill on the Horizon, RestorationEze Discusses the Impact an Aging Sewer System is Having on Homeowners 3Health News:Maryland Brain & Spine Announces New Specialty, New Name 2Health News:Maryland Brain & Spine Announces New Specialty, New Name 3Health News:Maryland Brain & Spine Announces New Specialty, New Name 4
... Infectious Diseases Society of America (IDSA) has asked for a ... further the Society,s mission to achieve the development of 10 ... 10 x ,20 Initiative. The World Health Organization (WHO) ... threats to human health. A new European Union report ...
... , INDIANAPOLIS, Nov. 23 ... a free app designed to help people with diabetes better manage ... and what they can do to better manage their blood sugar. ... of Glucose Buddy available now. , Roche Diabetes Care, the maker ...
... Victory Pharma, Inc. ("Victory") announced today the launch of ... , NAPRELAN Dose Card is designed for patients who require ... associated with primary dysmenorrhea and acute tendinitis and bursitis. ... or osteoarthritis who may be receiving other therapies and need ...
... November 23, 2009 In the November issue of ... journal of the American Society for Gastrointestinal Endoscopy (ASGE), ... esophagus was detected in six percent of asymptomatic women ... examined endoscopic ultrasound (EUS): Researchers from France, in the ...
... of a brain peptide called amyloid-beta. That,s why eliminating ... drug research pursuing a cure for the devastating neurodegenerative ... Inna Slutsky of Tel Aviv University,s Department of Physiology ... demonstrates that amyloid-beta is also necessary to maintain proper ...
... Ann Taylor Stores Corp. announced today that it will ... annual Thanks and Giving campaign, a holiday fundraising and awareness ... the third year that Ann Taylor, through its ANN CARES ... offer our shoppers an opportunity to help save children,s lives ...
Cached Medicine News:Health News:10 x '20: ID experts call for 10 new antibiotics by 2020 2Health News:10 x '20: ID experts call for 10 new antibiotics by 2020 3Health News:ACCU-CHEK(R) Partners With MYLEstone Health to Enhance iPhone App Glucose Buddy and Web Site glucosebuddy.com 2Health News:ACCU-CHEK(R) Partners With MYLEstone Health to Enhance iPhone App Glucose Buddy and Web Site glucosebuddy.com 3Health News:Victory Pharma, Inc. Announces Launch of NAPRELAN(R) Dose Card 2Health News:Study highlights from November issue of GIE: Gastrointestinal Endoscopy 2Health News:Study highlights from November issue of GIE: Gastrointestinal Endoscopy 3Health News:Study highlights from November issue of GIE: Gastrointestinal Endoscopy 4Health News:Study highlights from November issue of GIE: Gastrointestinal Endoscopy 5Health News:Upending textbook science on Alzheimer's disease 2Health News:Ann Taylor Stores Corp. Returns To St. Jude Children's Research Hospital's Thanks and Giving Campaign(R) For The Third Year 2
When You Need Optimal Patient Comfort with Minimal Weight at a Nonunion Site...Demand The OrthoPak Noninvasive Bone Growth Stimulator., ,Most Appropriate for the Proximal Femur, Metatarsal/Tarsal...
... Providing the surgical versatility you demand ... fractures.,The new EBI OsteoGen-D offers 40 microamperes ... leads each with 20 microamperes. Available in ... provides superior flexibility with any of your ...
... of patients requiring cataract surgery following refractive ... created a challenge for surgeons, as calculating ... difficult. True corneal power following RK, ALK, ... measure by keratometry or topography. For example, ...
... Stryker is proud to ... resectoscopes on the market at ... ergonomic design incorporates a superior ... and intuitive locking mechanisms. The ...
Medicine Products: